Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
Portfolio Pulse from Benzinga Neuro
Senator Bernie Sanders criticized the U.S. healthcare system, highlighting the disparity in life expectancy between rich and poor Americans. He emphasized the high cost of healthcare and its financial burden on patients, mentioning companies like Biogen and Bristol-Myers Squibb for their high drug prices.
September 10, 2024 | 2:12 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Biogen is criticized by Bernie Sanders for high drug prices, which he argues contribute to the financial burden on patients and healthcare disparities in the U.S.
Sanders' criticism of high drug prices directly targets Biogen, potentially affecting its public image and investor sentiment negatively in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Bristol-Myers Squibb is mentioned by Bernie Sanders for its high drug prices, which he claims exacerbate healthcare inequalities in the U.S.
Sanders' remarks on high drug prices include Bristol-Myers Squibb, likely affecting its reputation and investor confidence negatively in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70